Despite the rising incidence of some HPV-related cancers, vaccine coverage rates remain low.
Although the overall incidence of cancer continues to decline in U.S. men and women, a new annual report from the American Cancer Society, Centers for Disease Control and Prevention, National Cancer Institute, and North American Association of Central Cancer Registries shows that rates of certain human papillomavirus (HPV)-related cancers (anus, oropharynx) have risen from 2000 to 2009. These malignancies — along with cervical cancer, which represents more than half of all HPV-related cancers in women — disproportionately affect blacks and low-income individuals, and are the very cancers that could eventually be eliminated by routine use of the prophylactic HPV-16/18 vaccine.
HPV vaccine uptake among adolescent women continues to be suboptim…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)